CTXR
NASDAQ
US
Citius Pharmaceuticals, Inc. - Common Stock
$0.85
▲ +$0.01
(+1.30%)
Vol 264K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$16.1M
ROE
-62.0%
D/E
1.54
Beta
1.55
52W
$1–$6
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%
Next Report
May 12, 2026
EPS Estimate: $-0.20
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2026 | $-0.20 | — | — |
| Sep 2025 | $-0.50 | $-0.72 | $-0.22 |
| Jun 2025 | $-0.60 | $-0.80 | $-0.20 |
| Mar 2025 | $-0.39 | $-1.27 | $-0.88 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $3.9M |
| Net Income | — | -$9.8M | -$10.9M | -$8.8M | -$8.0M | -$8.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -62.0% | -61.7% | -61.7% | -61.7% | -62.0% | -62.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
| Current Ratio | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Key Ratios
ROA (TTM)
-33.3%
P/B
1.3
EPS (TTM)
$-4.90
CF/Share
$-0.21
52W High
$5.95
52W Low
$0.63
$0.63
52-Week Range
$5.95
Financial Health
Free Cash Flow
-$13.0M
Net Debt
-$5.9M
Cash
$7.7M
Total Debt
$1.8M
As of Dec 31, 2025
How does CTXR compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CTXR valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.3
▼
39%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CTXR profitability vs Pharmaceuticals peers
ROE
-62.0%
▼
14%
below
peers
(-54.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-33.3%
▲
11%
above
peers
(-37.4%)
vs Peers
vs Industry
In line
CTXR financial health vs Pharmaceuticals peers
D/E ratio
1.5
▲
0%
above
peers
(1.5)
vs Peers
vs Industry
In line
Current ratio
0.5
▼
86%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.6
▲
65%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
CTXR fundamentals radar
CTXR
Peer median
Industry
CTXR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CTXR vs peers: key metrics
Top Holders
Top 5: 5.85%Heights Capital Management,…
3.57%
$575K
Vanguard Group Inc
0.89%
$143K
Geode Capital Management, L…
0.57%
$92K
Xtx Topco Ltd
0.48%
$77K
UBS Group AG
0.34%
$55K
As of Dec 31, 2025
Latest News
No related news yet